blog

Going the Extra Mile: RSG® Arrive Driver of the Month

By Elizabeth Gargill on Fri, May 3, 2019 | 2 min read

BBK’s RSG® Arrive patient travel program continues to stand out in an increasingly crowded marketplace of companies offering concierge travel and ride-hailing services. One of the reasons RSG® Arrive is in a class by itself is the dedication, commitment to care, and professionalism of its drivers. They routinely go above and beyond to ensure the comfort and care of their passengers.

Viken-Mardirossian-Square

To recognize the important role that our RSG® Arrive drivers play in enhancing the clinical trial patient experience, we will be celebrating a driver of the month, starting this month with Viken.

Topics: Patient Travel, Patient Experience

The Impact a Travel Program Can Have on Your Patient Recruitment and Engagement Success

By BBK Worldwide on Mon, Jan 7, 2019 | 2 min read

When it comes to the benefits travel programs offer in support of clinical trials, opinions are varied. In a recent article published in International Clinical Trials, BBK’s Hannu Koski and Rob Laurens present compelling data with industry insights. “Talking Travel” looks at the appeal travel assistance programs have from the patients’ perspective.

Topics: Patient Retention, Patient Recruitment, Trends, Patient Travel, Patient Experience, Patient Data, Travel Programs

Uber, Lyft, and Emergency Care: CEO of BBK Worldwide, Joan F. Bachenheimer Responds to The New York Times

By Joan F. Bachenheimer on Thu, Oct 18, 2018 | 4 min read

You might have seen an article in the October 1 issue of The New York Times, titled “Uber, Lyft and the Urgency of Saving Money on Ambulances,” by Austin Frakt. The article pushed for alternative modes of transportation in medical situations – such as Uber and Lyft – as cost-saving measures.

CEO and Founding Principal of BBK Worldwide, Joan F. Bachenheimer, wrote a strong response to the article, which has been submitted to the Times as a Letter to the Editor. We would love to hear your thoughts on possible use of ride-sharing apps like Uber or Lyft for emergency services.

 

Topics: Patient Retention, Patient Engagement, Patient Travel, Patient Experience

Empowering Patients with Innovative Tech & Strategies

By BBK on Fri, Mar 31, 2017 | 2 min read

Medication non-compliance is an epidemic that impacts patients, sponsors and the healthcare industry at large, costing the U.S. healthcare system around 300 billion dollars a year. According to a PM360 article that highlights medication compliance in diabetes patient populations, non-adherent patients have inpatient healthcare costs that are 41% higher than those of adherent patients. 

Topics: Patient Retention, mHealth, Clinical Research, Patient Travel

RSG® Arrive: Patient Travel Program Takes Patient-Centric Approach

By BBK on Tue, Aug 18, 2015 | 3 min read

Last week on the blog we highlighted BBK’s RSG® Arrive service, which underscores our commitment to patient centricity by easing study visit travel complexities and in turn, expanding clinical research participation. We know that travel can be a hassle, but what if getting a patient to a site could mean the difference between receiving a potentially life-saving treatment or not? What makes a patient travel program such an integral part of the clinical trial landscape?

Topics: Patient Centricity, Patient Travel

Taking the Burden Out of Patient Travel with RSG® Arrive

By BBK on Tue, Aug 4, 2015 | 2 min read

Imagine a program that takes the hassle out of patient travel within a clinical trial. When dealing with a condition of any sort, be it rare or otherwise, asking a patient to travel across state lines or even to another country, can be a source of anxiety and for many, a financial hardship. Many rare diseases especially, affect newborns who require a parent or guardian to handle travel logistics and accompany the patient. In many instances, travel can affect an entire family not once, but for multiple site visits throughout the course of a study. If not the patients themselves, many parents, guardians or caregivers determine that the complexity involved in getting to a site might outweigh the benefits of participation in a clinical trial. But what if the burden associated with travel could be eliminated?

Topics: Patient Travel

 
Subscribe To Our Blog